LON:CNSL Cambridge Nutritional Sciences (CNSL) Share Price, News & Analysis GBX 1.94 0.00 (0.00%) As of 05/18/2026 05:59 AM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsEarningsInsider TradesBuy This Stock About Cambridge Nutritional Sciences Stock (LON:CNSL) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get CNSL alerts:Sign Up Key Stats Today's Range 1.91▼ 2.2050-Day Range 1.70▼ 2.2052-Week Range 1.70▼ 4.33Volume2,510 shsAverage Volume214,140 shsMarket Capitalization£4.63 millionP/E Ratio3.24Dividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Cambridge Nutritional Sciences plc (AIM: CNSL) is a specialist medical diagnostics company focused on promoting a personalised and functional approach to health and nutrition. Read More Receive CNSL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cambridge Nutritional Sciences and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CNSL Stock News HeadlinesCambridge Nutritional Sciences Leadership Increases ShareholdingsNovember 19, 2025 | tipranks.comCambridge Nutritional Sciences Faces Historical Legal ChallengeJanuary 21, 2025 | tipranks.comLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top S&P 500 stock for 12 years running—and today, he's giving away his #1 AI stock pick for 2026, free. This company's sales are up 28% year over year, it holds over 30,000 patents in wireless and video technology, and it just earned an A-rating in his proprietary Stock Grader system that has cost him $9 million to build and maintain. | InvestorPlace (Ad)Cambridge Nutritional Sciences Resolves Legal Dispute with DHSCJanuary 16, 2025 | tipranks.comSee More Headlines CNSL Stock Analysis - Frequently Asked Questions How have CNSL shares performed this year? Cambridge Nutritional Sciences' stock was trading at GBX 1.94 at the beginning of the year. Since then, CNSL stock has increased by 0.1% and is now trading at GBX 1.95. How were Cambridge Nutritional Sciences' earnings last quarter? Cambridge Nutritional Sciences plc (LON:CNSL) posted its quarterly earnings data on Monday, November, 10th. The company reported ($0.20) earnings per share for the quarter. Cambridge Nutritional Sciences had a trailing twelve-month return on equity of 12.15% and a net margin of 16.94%. How do I buy shares of Cambridge Nutritional Sciences? Shares of CNSL stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. Company Calendar Last Earnings11/10/2025Today5/18/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Medical Instruments & Supplies Sub-IndustryCommunication Current SymbolLON:CNSL CIKN/A Webwww.cnsplc.com Phone(217) 235-3311FaxN/AEmployees3,200Year FoundedN/AProfitability EPS (Trailing Twelve Months)GBX 0.60 Trailing P/E Ratio3.24 Forward P/E Ratio52.76 P/E GrowthN/ANet Income-£3.03 million Net Margins16.94% Pretax MarginN/A Return on Equity12.15% Return on Assets-2.36% Debt Debt-to-Equity Ratio2.14 Current Ratio4.25 Quick RatioN/A Sales & Book Value Annual Sales£8.06 million Price / Sales0.57 Cash FlowN/A Price / Cash FlowN/A Book ValueGBX 4 per share Price / Book0.49Miscellaneous Outstanding Shares237,951,000Free FloatN/AMarket Cap£4.63 million OptionableN/A Beta2.10 Beginner's Guide To Retirement StocksClick the link to see MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report This page (LON:CNSL) was last updated on 5/19/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | SponsoredIran's New Leader Just Said Something That Should Terrify Every AmericanIran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...American Alternative | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredWhy this tiny stock may move before the SpaceX IPO dropsThe projected SpaceX and xAI S-1 filing hits the SEC on June 1st - and analyst Dylan Jovine says $1.75 trillio...Behind the Markets | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cambridge Nutritional Sciences plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Cambridge Nutritional Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
